Compare · CTRE vs VTR
CTRE vs VTR
Side-by-side comparison of CareTrust REIT Inc. (CTRE) and Ventas Inc. (VTR): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both CTRE and VTR operate in Real Estate Investment Trusts (Real Estate), so they compete in similar markets.
- VTR is the larger of the two at $44.76B, about 22.1x CTRE ($2.02B).
- Over the past year, CTRE is up 29.8% and VTR is up 41.0% - VTR leads by 11.3 points.
- VTR has hit the wire 7 times in the past 4 weeks while CTRE has been quiet.
- Both have 25 recent analyst ratings on file.
- Company
- CareTrust REIT Inc.
- Ventas Inc.
- Price
- $40.58+0.58%
- $92.50+0.47%
- Market cap
- $2.02B
- $44.76B
- 1M return
- +10.38%
- +10.26%
- 1Y return
- +29.76%
- +41.02%
- Industry
- Real Estate Investment Trusts
- Real Estate Investment Trusts
- Exchange
- NASDAQ
- NYSE
- IPO
- 2022
- News (4w)
- 0
- 7
- Recent ratings
- 25
- 25
CareTrust REIT Inc.
CareTrust REIT, Inc. is a self-administered, publicly-traded real estate investment trust engaged in the ownership, acquisition, development and leasing of skilled nursing, seniors housing and other healthcare-related properties. With a nationwide portfolio of long-term net-leased properties, and a growing portfolio of quality operators leasing them, CareTrust REIT is pursuing both external and organic growth opportunities across the United States.
Ventas Inc.
Ventas, an S&P 500 company, operates at the intersection of two powerful and dynamic industries  healthcare and real estate. As one of the world's foremost Real Estate Investment Trusts (REIT), we use the power of capital to unlock the value of real estate, partnering with leading care providers, developers, research and medical institutions, innovators and healthcare organizations whose success is buoyed by the demographic tailwind of an aging population. For more than twenty years, Ventas has followed a successful strategy that endures: combining a high-quality diversified portfolio of properties and capital sources to manage through cycles, working with industry leading partners, and a collaborative and experienced team focused on producing consistent growing cash flows and superior returns on a strong balance sheet, ultimately rewarding Ventas shareholders. As of September 30, 2020, Ventas owned or managed through unconsolidated joint ventures approximately 1,200 properties.
Latest CTRE
- Raymond James resumed coverage on CareTrust REIT with a new price target
- CareTrust REIT Announces Quarterly Dividend of $0.39 per Share
- CareTrust REIT Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits
- CareTrust REIT Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits
- SEC Form 424B5 filed by CareTrust REIT Inc.
- CareTrust REIT, Inc. Announces Pricing of Upsized Public Offering of Common Stock
- SEC Form 424B5 filed by CareTrust REIT Inc.
- CareTrust REIT, Inc. Announces Launch of Public Offering of Common Stock
- Amendment: SEC Form SCHEDULE 13G/A filed by CareTrust REIT Inc.
- CareTrust REIT Announces First Quarter 2026 Operating Results; Increases 2026 Guidance
Latest VTR
- Barclays initiated coverage on Ventas with a new price target
- Director Smith Maurice S was granted 461 shares, increasing direct ownership by 2% to 31,184 units (SEC Form 4)
- Director Roy Sumit was granted 349 shares, increasing direct ownership by 1% to 24,753 units (SEC Form 4)
- Director Martino Roxanne M was granted 544 shares, increasing direct ownership by 0.82% to 66,672 units (SEC Form 4)
- Director Lustig Matthew J was granted 448 shares, increasing direct ownership by 0.47% to 95,453 units (SEC Form 4)
- Ventas Announces Second Quarter 2026 Earnings Release Date and Conference Call
- Ventas Names Andrew L. Wattula EVP Outpatient Medical & Research
- Raymond James resumed coverage on Ventas with a new price target
- Ventas Inc. filed SEC Form 8-K: Leadership Update, Other Events
- Director Embler Michael J bought $197,025 worth of shares (2,500 units at $78.81), increasing direct ownership by 15% to 19,202 units (SEC Form 4)